SIRT1 and metabolic dysfunction-associated steatotic liver disease: SIRT1, a NAD+-dependent deacetylase that plays a key role in the regulation of lipid and glucose homeostasis, regulation of mitochondrial biogenesis, and control of insulin sensitivity and oxidative stress, may also serve as a potential therapeutic target for treating NAFLD [132].